Ribonuclease Inhibitors

InformationABBV-744 ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2, BRD3 and BRD4. It is developed for treating AML and cancers.In vitroABBV-744 is a potent inhibitor specific for BDII of BRD2/3/4, with &gt:250-fold

Acetobromo-α-D-glucuronic acid methyl ester is used for the synthesis of HMR1098-S-Glucuronide Methyl Ester, a new K-ATP-blocking agent being developed as a drug for prevention of sudden cardiac death.

Acetobromo-α-D-glucuronic acid methyl ester is used for the synthesis of HMR1098-S-Glucuronide Methyl Ester, a new K-ATP-blocking agent being developed as a drug for prevention of sudden cardiac death.

Acetobromo-α-D-glucuronic acid methyl ester is used for the synthesis of HMR1098-S-Glucuronide Methyl Ester, a new K-ATP-blocking agent being developed as a drug for prevention of sudden cardiac death.

Acetobromo-α-D-glucuronic acid methyl ester is used for the synthesis of HMR1098-S-Glucuronide Methyl Ester, a new K-ATP-blocking agent being developed as a drug for prevention of sudden cardiac death.

Anti-ADD3 adducin 3 (gamma), 100ul UN 1687 6.1 PG2

Anti-ADPRH ADP-ribosylarginine hydrolase, 100ul UN 1687 6.1

Anti-ADPRH ADP-ribosylarginine hydrolase, 25ul UN 1687 6.1 P

Anti-ALG2 ALG2, alpha-1,3/1,6-mannosyltransferase, 100ul UN

Anti-AMD1 adenosylmethionine decarboxylase 1, 100ul UN 1687

Anti-ARFIP2 ADP-ribosylation factor interacting protein 2, 1

Anti-ARFRP1 ADP-ribosylation factor related protein 1, 100ul